TIGIT and neoplasm: Their results indicate that the expression of TIM-3 and also TIGIT, PD-1, CD39 on Vδ1 cells differs among PBLs, MALs and TILs (tumor-infiltrating lymphocytes) in patients with OC and is dependent on interactions with the tumor microenvironment.